Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice.
about
Evidence for differential effects of apoE3 and apoE4 on HDL metabolismLow-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependentRegression of atherosclerosis: insights from animal and clinical studiesGolgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein EReduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.The key role of apolipoprotein E in atherosclerosis.ApoE plasma levels and risk of cardiovascular mortality in old ageApolipoprotein E and coronary disease: a puzzling paradox.An inducible and reversible mouse genetic rescue system.Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein ELifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vectorAdvances in experimental dyslipidemia and atherosclerosis.Anti-oxidant properties of high-density lipoprotein and atherosclerosisBeyond endocytosis: LRP function in cell migration, proliferation and vascular permeability.Recent advances in liver-directed gene therapy for dyslipidemia.Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imagingApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endotheliumAPOE Polymorphism Is Associated with C-reactive Protein Levels but Not with White Blood Cell Count: Dong-gu Study and Namwon StudyAnimal models of atherosclerosis.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial HypercholesterolemiaApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout miceInfluence of PDZK1 on lipoprotein metabolism and atherosclerosis.ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation.ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesisRapid regression of atherosclerosis: insights from the clinical and experimental literature.Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.Role of apolipoprotein E genotype in coronary artery disease.Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor.Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wallLecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism.Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia.Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase.
P2860
Q24313446-EA2CDFF2-0C0A-4197-9E8E-8F762EA1661FQ24628806-E23CBE19-6F64-4251-878E-7D353CF1E1E9Q27028112-449E39F9-ACE9-4F6C-A327-F524E9C71B32Q28577984-AD52A7BC-F426-4545-98B7-F5D4BA27D94DQ31452265-33DE2AAE-6DF1-422F-AD1F-2919C3E7C183Q33213990-E3825DB7-4169-4CBA-8EE2-65BCED0F373FQ33242076-C28F0ADB-8FD7-4E77-A61B-AF6E932AAF2AQ33244905-4528A166-27F8-4F99-950E-42466EB72DC1Q33332589-F8D80C6A-3EE2-4A52-8625-0D31CE68A4E2Q33344456-24F62EBA-4BD7-4C8A-95AB-AAC9F40C9B21Q33949311-18F030CE-75CB-49E5-8111-8041F0F1337CQ34368686-4696461C-66C1-4304-951F-0751C66917D5Q34440172-6750301A-3968-4EB5-8704-E67C3825D139Q34443186-DD23DBB2-C07E-4347-9E99-BDC58734E7AAQ34586826-F9459DF8-1BB7-4D7A-9EA6-D3D0C2B27E02Q35014212-5C2E43F8-01F6-4093-A382-FCD43B7A20BFQ35098355-464C37A5-359F-4631-B0AB-09C80CB1BE01Q35561963-8124E797-BA94-44D9-BD25-8A9ACBD3683CQ35744441-346E2ECF-808B-41A9-B9E6-868A8B1442C6Q35778546-972A1D27-8439-4F18-B30F-B960EC4E23DDQ35903298-930B3718-822A-425B-B5C0-E82C31E2EA3FQ35974993-E7300EC8-4ACE-4682-9647-94B520B4A3D9Q36344509-8A6965BE-8DA7-40DD-B87F-F5A6636E9ED1Q36462065-6B9DBB97-7A1B-4CD8-9F6B-083B325616B5Q36708971-DAF59B45-8635-4FB4-8E0E-A99517A82B41Q36804822-ED8B9CF8-BA99-4C8A-92C6-785936109874Q36843340-7FDC33E3-EF5F-4B7D-A632-8F6FC4FF3BA3Q37068628-382C4920-6262-4DD2-BC8D-E3A714A34BEDQ37330045-BB9B89AA-E08A-481C-B179-E5705DDF1255Q37597603-7D8B0794-E2C0-4CD5-B049-F39EC040ACB9Q37608596-061D7DFE-1126-4243-9CB4-EBA7229C1455Q38747495-E61292DB-FEDE-4485-BCF5-1B62E330DB0AQ38888696-0AFB2E75-795C-4793-BB4C-05DA14D1EF1EQ40428631-EF7E4629-B398-406D-B74B-4498FEFF7AF5Q41902903-3FE8EFA0-419B-4219-83CC-6ECBEB24BBC6Q42019558-6E09035B-D60C-4E09-A1E8-AEA8E554525CQ43806634-4CE7F828-5DE0-450D-8EEE-6DB1679AEBB9Q43855742-66644214-473E-4FB0-9693-68915F0456F0Q44138790-5C335B2A-C159-437C-8CE8-08ABD1DB4D12Q44243384-055A8241-2C6E-4014-8A07-9BB0DD98CDF8
P2860
Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@ast
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@en
type
label
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@ast
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@en
prefLabel
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@ast
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@en
P2093
P356
P1476
Low levels of extrahepatic non ...... olemia in ApoE-deficient mice.
@en
P2093
Thorngate FE
Williams DL
P304
P356
10.1161/01.ATV.20.8.1939
P407
P577
2000-08-01T00:00:00Z